1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Restless Legs Syndrome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Pharmacological Therapy 1.2.3 Non-Pharmacological Therapy 1.3 Market by Application 1.3.1 Global Restless Legs Syndrome Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Below 35 YearsOld 1.3.3 35-50 Years Old 1.3.4 Above50 YearsOld 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Restless Legs Syndrome Market Perspective (2016-2027) 2.2 Restless Legs Syndrome Growth Trends by Regions 2.2.1 Restless Legs Syndrome Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Restless Legs Syndrome Historic Market Share by Regions (2016-2021) 2.2.3 Restless Legs Syndrome Forecasted Market Size by Regions (2022-2027) 2.3 Restless Legs Syndrome Industry Dynamic 2.3.1 Restless Legs Syndrome Market Trends 2.3.2 Restless Legs Syndrome Market Drivers 2.3.3 Restless Legs Syndrome Market Challenges 2.3.4 Restless Legs Syndrome Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Restless Legs Syndrome Players by Revenue 3.1.1 Global Top Restless Legs Syndrome Players by Revenue (2016-2021) 3.1.2 Global Restless Legs Syndrome Revenue Market Share by Players (2016-2021) 3.2 Global Restless Legs Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Restless Legs Syndrome Revenue 3.4 Global Restless Legs Syndrome Market Concentration Ratio 3.4.1 Global Restless Legs Syndrome Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Restless Legs Syndrome Revenue in 2020 3.5 Restless Legs Syndrome Key Players Head office and Area Served 3.6 Key Players Restless Legs Syndrome Product Solution and Service 3.7 Date of Enter into Restless Legs Syndrome Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Restless Legs Syndrome Breakdown Data by Type 4.1 Global Restless Legs Syndrome Historic Market Size by Type (2016-2021) 4.2 Global Restless Legs Syndrome Forecasted Market Size by Type (2022-2027) 5 Restless Legs Syndrome Breakdown Data by Application 5.1 Global Restless Legs Syndrome Historic Market Size by Application (2016-2021) 5.2 Global Restless Legs Syndrome Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Restless Legs Syndrome Market Size (2016-2027) 6.2 North America Restless Legs Syndrome Market Size by Type 6.2.1 North America Restless Legs Syndrome Market Size by Type (2016-2021) 6.2.2 North America Restless Legs Syndrome Market Size by Type (2022-2027) 6.2.3 North America Restless Legs Syndrome Market Size by Type (2016-2027) 6.3 North America Restless Legs Syndrome Market Size by Application 6.3.1 North America Restless Legs Syndrome Market Size by Application (2016-2021) 6.3.2 North America Restless Legs Syndrome Market Size by Application (2022-2027) 6.3.3 North America Restless Legs Syndrome Market Size by Application (2016-2027) 6.4 North America Restless Legs Syndrome Market Size by Country 6.4.1 North America Restless Legs Syndrome Market Size by Country (2016-2021) 6.4.2 North America Restless Legs Syndrome Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Restless Legs Syndrome Market Size (2016-2027) 7.2 Europe Restless Legs Syndrome Market Size by Type 7.2.1 Europe Restless Legs Syndrome Market Size by Type (2016-2021) 7.2.2 Europe Restless Legs Syndrome Market Size by Type (2022-2027) 7.2.3 Europe Restless Legs Syndrome Market Size by Type (2016-2027) 7.3 Europe Restless Legs Syndrome Market Size by Application 7.3.1 Europe Restless Legs Syndrome Market Size by Application (2016-2021) 7.3.2 Europe Restless Legs Syndrome Market Size by Application (2022-2027) 7.3.3 Europe Restless Legs Syndrome Market Size by Application (2016-2027) 7.4 Europe Restless Legs Syndrome Market Size by Country 7.4.1 Europe Restless Legs Syndrome Market Size by Country (2016-2021) 7.4.2 Europe Restless Legs Syndrome Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Restless Legs Syndrome Market Size (2016-2027) 8.2 Asia-Pacific Restless Legs Syndrome Market Size by Type 8.2.1 Asia-Pacific Restless Legs Syndrome Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Restless Legs Syndrome Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Restless Legs Syndrome Market Size by Type (2016-2027) 8.3 Asia-Pacific Restless Legs Syndrome Market Size by Application 8.3.1 Asia-Pacific Restless Legs Syndrome Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Restless Legs Syndrome Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Restless Legs Syndrome Market Size by Application (2016-2027) 8.4 Asia-Pacific Restless Legs Syndrome Market Size by Region 8.4.1 Asia-Pacific Restless Legs Syndrome Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Restless Legs Syndrome Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Restless Legs Syndrome Market Size (2016-2027) 9.2 Latin America Restless Legs Syndrome Market Size by Type 9.2.1 Latin America Restless Legs Syndrome Market Size by Type (2016-2021) 9.2.2 Latin America Restless Legs Syndrome Market Size by Type (2022-2027) 9.2.3 Latin America Restless Legs Syndrome Market Size by Type (2016-2027) 9.3 Latin America Restless Legs Syndrome Market Size by Application 9.3.1 Latin America Restless Legs Syndrome Market Size by Application (2016-2021) 9.3.2 Latin America Restless Legs Syndrome Market Size by Application (2022-2027) 9.3.3 Latin America Restless Legs Syndrome Market Size by Application (2016-2027) 9.4 Latin America Restless Legs Syndrome Market Size by Country 9.4.1 Latin America Restless Legs Syndrome Market Size by Country (2016-2021) 9.4.2 Latin America Restless Legs Syndrome Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Restless Legs Syndrome Market Size (2016-2027) 10.2 Middle East & Africa Restless Legs Syndrome Market Size by Type 10.2.1 Middle East & Africa Restless Legs Syndrome Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Restless Legs Syndrome Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Restless Legs Syndrome Market Size by Type (2016-2027) 10.3 Middle East & Africa Restless Legs Syndrome Market Size by Application 10.3.1 Middle East & Africa Restless Legs Syndrome Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Restless Legs Syndrome Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Restless Legs Syndrome Market Size by Application (2016-2027) 10.4 Middle East & Africa Restless Legs Syndrome Market Size by Country 10.4.1 Middle East & Africa Restless Legs Syndrome Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Restless Legs Syndrome Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 GlaxoSmithKline plc. 11.1.1 GlaxoSmithKline plc. Company Details 11.1.2 GlaxoSmithKline plc. Business Overview 11.1.3 GlaxoSmithKline plc. Restless Legs Syndrome Introduction 11.1.4 GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (2016-2021) 11.1.5 GlaxoSmithKline plc. Recent Development 11.2 Ligand Pharmaceuticals Incorporated 11.2.1 Ligand Pharmaceuticals Incorporated Company Details 11.2.2 Ligand Pharmaceuticals Incorporated Business Overview 11.2.3 Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Introduction 11.2.4 Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (2016-2021) 11.2.5 Ligand Pharmaceuticals Incorporated Recent Development 11.3 axxonis Pharma AG 11.3.1 axxonis Pharma AG Company Details 11.3.2 axxonis Pharma AG Business Overview 11.3.3 axxonis Pharma AG Restless Legs Syndrome Introduction 11.3.4 axxonis Pharma AG Revenue in Restless Legs Syndrome Business (2016-2021) 11.3.5 axxonis Pharma AG Recent Development 11.4 Kyowa Hakko Kirin 11.4.1 Kyowa Hakko Kirin Company Details 11.4.2 Kyowa Hakko Kirin Business Overview 11.4.3 Kyowa Hakko Kirin Restless Legs Syndrome Introduction 11.4.4 Kyowa Hakko Kirin Revenue in Restless Legs Syndrome Business (2016-2021) 11.4.5 Kyowa Hakko Kirin Recent Development 11.5 Jazz Pharmaceuticals 11.5.1 Jazz Pharmaceuticals Company Details 11.5.2 Jazz Pharmaceuticals Business Overview 11.5.3 Jazz Pharmaceuticals Restless Legs Syndrome Introduction 11.5.4 Jazz Pharmaceuticals Revenue in Restless Legs Syndrome Business (2016-2021) 11.5.5 Jazz Pharmaceuticals Recent Development 11.6 Omeros Corporation 11.6.1 Omeros Corporation Company Details 11.6.2 Omeros Corporation Business Overview 11.6.3 Omeros Corporation Restless Legs Syndrome Introduction 11.6.4 Omeros Corporation Revenue in Restless Legs Syndrome Business (2016-2021) 11.6.5 Omeros Corporation Recent Development 11.7 Manhattan Pharmaceuticals 11.7.1 Manhattan Pharmaceuticals Company Details 11.7.2 Manhattan Pharmaceuticals Business Overview 11.7.3 Manhattan Pharmaceuticals Restless Legs Syndrome Introduction 11.7.4 Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (2016-2021) 11.7.5 Manhattan Pharmaceuticals Recent Development 11.8 Boehringer Ingelheim GmbH 11.8.1 Boehringer Ingelheim GmbH Company Details 11.8.2 Boehringer Ingelheim GmbH Business Overview 11.8.3 Boehringer Ingelheim GmbH Restless Legs Syndrome Introduction 11.8.4 Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (2016-2021) 11.8.5 Boehringer Ingelheim GmbH Recent Development 11.9 UCB SA 11.9.1 UCB SA Company Details 11.9.2 UCB SA Business Overview 11.9.3 UCB SA Restless Legs Syndrome Introduction 11.9.4 UCB SA Revenue in Restless Legs Syndrome Business (2016-2021) 11.9.5 UCB SA Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Restless Legs Syndrome Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Pharmacological Therapy Table 3. Key Players of Non-Pharmacological Therapy Table 4. Global Restless Legs Syndrome Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Restless Legs Syndrome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Restless Legs Syndrome Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Restless Legs Syndrome Market Share by Regions (2016-2021) Table 8. Global Restless Legs Syndrome Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Restless Legs Syndrome Market Share by Regions (2022-2027) Table 10. Restless Legs Syndrome Market Trends Table 11. Restless Legs Syndrome Market Drivers Table 12. Restless Legs Syndrome Market Challenges Table 13. Restless Legs Syndrome Market Restraints Table 14. Global Restless Legs Syndrome Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Restless Legs Syndrome Market Share by Players (2016-2021) Table 16. Global Top Restless Legs Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Restless Legs Syndrome as of 2020) Table 17. Ranking of Global Top Restless Legs Syndrome Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Restless Legs Syndrome Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Restless Legs Syndrome Product Solution and Service Table 21. Date of Enter into Restless Legs Syndrome Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Restless Legs Syndrome Market Size by Type (2016-2021) (US$ Million) Table 24. Global Restless Legs Syndrome Revenue Market Share by Type (2016-2021) Table 25. Global Restless Legs Syndrome Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Restless Legs Syndrome Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Restless Legs Syndrome Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Restless Legs Syndrome Revenue Market Share by Application (2016-2021) Table 29. Global Restless Legs Syndrome Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Restless Legs Syndrome Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Restless Legs Syndrome Market Size by Type (2016-2021) (US$ Million) Table 32. North America Restless Legs Syndrome Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Restless Legs Syndrome Market Size by Application (2016-2021) (US$ Million) Table 34. North America Restless Legs Syndrome Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Restless Legs Syndrome Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Restless Legs Syndrome Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Restless Legs Syndrome Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Restless Legs Syndrome Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Restless Legs Syndrome Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Restless Legs Syndrome Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Restless Legs Syndrome Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Restless Legs Syndrome Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Restless Legs Syndrome Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Restless Legs Syndrome Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Restless Legs Syndrome Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Restless Legs Syndrome Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Restless Legs Syndrome Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Restless Legs Syndrome Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Restless Legs Syndrome Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Restless Legs Syndrome Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Restless Legs Syndrome Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Restless Legs Syndrome Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Restless Legs Syndrome Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Restless Legs Syndrome Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Restless Legs Syndrome Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Restless Legs Syndrome Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Restless Legs Syndrome Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Restless Legs Syndrome Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Restless Legs Syndrome Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Restless Legs Syndrome Market Size by Country (2022-2027) & (US$ Million) Table 61. GlaxoSmithKline plc. Company Details Table 62. GlaxoSmithKline plc. Business Overview Table 63. GlaxoSmithKline plc. Restless Legs Syndrome Product Table 64. GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (2016-2021) & (US$ Million) Table 65. GlaxoSmithKline plc. Recent Development Table 66. Ligand Pharmaceuticals Incorporated Company Details Table 67. Ligand Pharmaceuticals Incorporated Business Overview Table 68. Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Product Table 69. Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (2016-2021) & (US$ Million) Table 70. Ligand Pharmaceuticals Incorporated Recent Development Table 71. axxonis Pharma AG Company Details Table 72. axxonis Pharma AG Business Overview Table 73. axxonis Pharma AG Restless Legs Syndrome Product Table 74. axxonis Pharma AG Revenue in Restless Legs Syndrome Business (2016-2021) & (US$ Million) Table 75. axxonis Pharma AG Recent Development Table 76. Kyowa Hakko Kirin Company Details Table 77. Kyowa Hakko Kirin Business Overview Table 78. Kyowa Hakko Kirin Restless Legs Syndrome Product Table 79. Kyowa Hakko Kirin Revenue in Restless Legs Syndrome Business (2016-2021) & (US$ Million) Table 80. Kyowa Hakko Kirin Recent Development Table 81. Jazz Pharmaceuticals Company Details Table 82. Jazz Pharmaceuticals Business Overview Table 83. Jazz Pharmaceuticals Restless Legs Syndrome Product Table 84. Jazz Pharmaceuticals Revenue in Restless Legs Syndrome Business (2016-2021) & (US$ Million) Table 85. Jazz Pharmaceuticals Recent Development Table 86. Omeros Corporation Company Details Table 87. Omeros Corporation Business Overview Table 88. Omeros Corporation Restless Legs Syndrome Product Table 89. Omeros Corporation Revenue in Restless Legs Syndrome Business (2016-2021) & (US$ Million) Table 90. Omeros Corporation Recent Development Table 91. Manhattan Pharmaceuticals Company Details Table 92. Manhattan Pharmaceuticals Business Overview Table 93. Manhattan Pharmaceuticals Restless Legs Syndrome Product Table 94. Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (2016-2021) & (US$ Million) Table 95. Manhattan Pharmaceuticals Recent Development Table 96. Boehringer Ingelheim GmbH Company Details Table 97. Boehringer Ingelheim GmbH Business Overview Table 98. Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (2016-2021) & (US$ Million) Table 99. Boehringer Ingelheim GmbH Recent Development Table 100. UCB SA Company Details Table 101. UCB SA Business Overview Table 102. UCB SA Restless Legs Syndrome Product Table 103. UCB SA Revenue in Restless Legs Syndrome Business (2016-2021) & (US$ Million) Table 104. UCB SA Recent Development Table 105. Research Programs/Design for This Report Table 106. Key Data Information from Secondary Sources Table 107. Key Data Information from Primary Sources List of Figures Figure 1. Global Restless Legs Syndrome Market Share by Type: 2020 VS 2027 Figure 2. Pharmacological Therapy Features Figure 3. Non-Pharmacological Therapy Features Figure 4. Global Restless Legs Syndrome Market Share by Application: 2020 VS 2027 Figure 5. Below 35 YearsOld Case Studies Figure 6. 35-50 Years Old Case Studies Figure 7. Above50 YearsOld Case Studies Figure 8. Restless Legs Syndrome Report Years Considered Figure 9. Global Restless Legs Syndrome Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Restless Legs Syndrome Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Restless Legs Syndrome Market Share by Regions: 2020 VS 2027 Figure 12. Global Restless Legs Syndrome Market Share by Regions (2022-2027) Figure 13. Global Restless Legs Syndrome Market Share by Players in 2020 Figure 14. Global Top Restless Legs Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Restless Legs Syndrome as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Restless Legs Syndrome Revenue in 2020 Figure 16. Global Restless Legs Syndrome Revenue Market Share by Type (2016-2021) Figure 17. Global Restless Legs Syndrome Revenue Market Share by Type (2022-2027) Figure 18. North America Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Restless Legs Syndrome Market Share by Type (2016-2027) Figure 20. North America Restless Legs Syndrome Market Share by Application (2016-2027) Figure 21. North America Restless Legs Syndrome Market Share by Country (2016-2027) Figure 22. United States Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Restless Legs Syndrome Market Share by Type (2016-2027) Figure 26. Europe Restless Legs Syndrome Market Share by Application (2016-2027) Figure 27. Europe Restless Legs Syndrome Market Share by Country (2016-2027) Figure 28. Germany Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Restless Legs Syndrome Market Share by Type (2016-2027) Figure 36. Asia-Pacific Restless Legs Syndrome Market Share by Application (2016-2027) Figure 37. Asia-Pacific Restless Legs Syndrome Market Share by Region (2016-2027) Figure 38. China Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Restless Legs Syndrome Market Share by Type (2016-2027) Figure 46. Latin America Restless Legs Syndrome Market Share by Application (2016-2027) Figure 47. Latin America Restless Legs Syndrome Market Share by Country (2016-2027) Figure 48. Mexico Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Restless Legs Syndrome Market Share by Type (2016-2027) Figure 52. Middle East & Africa Restless Legs Syndrome Market Share by Application (2016-2027) Figure 53. Middle East & Africa Restless Legs Syndrome Market Share by Country (2016-2027) Figure 54. Turkey Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Restless Legs Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. GlaxoSmithKline plc. Revenue Growth Rate in Restless Legs Syndrome Business (2016-2021) Figure 58. Ligand Pharmaceuticals Incorporated Revenue Growth Rate in Restless Legs Syndrome Business (2016-2021) Figure 59. axxonis Pharma AG Revenue Growth Rate in Restless Legs Syndrome Business (2016-2021) Figure 60. Kyowa Hakko Kirin Revenue Growth Rate in Restless Legs Syndrome Business (2016-2021) Figure 61. Jazz Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2016-2021) Figure 62. Omeros Corporation Revenue Growth Rate in Restless Legs Syndrome Business (2016-2021) Figure 63. Manhattan Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2016-2021) Figure 64. Boehringer Ingelheim GmbH Revenue Growth Rate in Restless Legs Syndrome Business (2016-2021) Figure 65. UCB SA Revenue Growth Rate in Restless Legs Syndrome Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

GlaxoSmithKline plc. Ligand Pharmaceuticals Incorporated axxonis Pharma AG Kyowa Hakko Kirin Jazz Pharmaceuticals Omeros Corporation Manhattan Pharmaceuticals Boehringer Ingelheim GmbH UCB SA